Enhanced human immunodeficiency virus infection in macrophages by high-molecular-weight dextran sulfate is associated with conformational changes of gp120 and expression of the CCR5 receptor

被引:11
|
作者
Jagodzinski, PP
Wierzbicki, A
Wustner, J
Kaneko, Y
Kozbor, D
机构
[1] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA
[2] Ajinomoto Co Inc, Chuoko 104, Japan
关键词
D O I
10.1089/vim.1999.12.23
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
High-molecular-weight dextran sulfate (HMDS) inhibits infection of CD4(+) lymphocytes by T-cell (T)-tropic human immunodeficiency virus (HIV) isolates, but augments replication of macrophage (M)-tropic isolates in primary human macrophages and phorbol myristate acetate (PMA)-differentiated THP-1 monocytic cells (27), To address the mechanism responsible for HMDS-mediated increases in HIV replication in macrophages, we analyzed the interaction between HMDS and functional domains of gp120 on the surface of PMA-differentiated THP-1 cells infected with M-tropic HIV isolates, Immunofluorescence staining of the infected cells revealed that HMDS inhibited the binding of monoclonal antibodies (mAbs) directed to the V3 and C4 domains of gp120, but augmented the binding of three neutralizing antibodies directed to the V2 region of gp120, The extent of HMDS-mediated changes within the V2 loop of gp120 was associated with increased virus binding and replication in PMA-differentiated THP-1 cells and primary macrophages. The effect was dependent on expression of the CCR5 receptor and was inhibited by the beta-chemokine RANTES. Results of this study suggest that HMDS-mediated increases in HIV infection in macrophages are associated with conformational changes within the V2 region of gp120 and enhanced interaction between gp120 and the CCR5 coreceptor on the target cell.
引用
收藏
页码:23 / 33
页数:11
相关论文
共 34 条
  • [1] A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5
    Farzan, M
    Choe, H
    Vaca, L
    Martin, K
    Sun, Y
    Desjardins, E
    Ruffing, N
    Wu, LJ
    Wyatt, R
    Gerard, N
    Gerard, C
    Sodroski, J
    JOURNAL OF VIROLOGY, 1998, 72 (02) : 1160 - 1164
  • [2] Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry
    Dragic, T
    Trkola, A
    Lin, SW
    Nagashima, KA
    Kajumo, F
    Zhao, L
    Olson, WC
    Wu, LJ
    Mackay, CR
    Allaway, GP
    Sakmar, TP
    Moore, JP
    Maddon, PJ
    JOURNAL OF VIROLOGY, 1998, 72 (01) : 279 - 285
  • [3] CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5
    Raja, A
    Venturi, M
    Kwong, P
    Sodroski, J
    JOURNAL OF VIROLOGY, 2003, 77 (01) : 713 - 718
  • [4] Resistance of a human immunodeficiency virus type 1 isolate to a small molecule CCR5 inhibitor can involve sequence changes in both gp120 and gp41
    Anastasopoulou, Cleo G.
    Ketas, Thomas J.
    Depetris, Rafael S.
    Thomas, Antonia M.
    Klasse, Per Johan
    Moore, John P.
    VIROLOGY, 2011, 413 (01) : 47 - 59
  • [5] Expression of CCR5, a chemokine receptor involved in human immunodeficiency virus (HIV-1) infection
    Loy, BA
    Guo, H
    Du, J
    Lear, SC
    Martin, AW
    Peiper, SC
    LABORATORY INVESTIGATION, 1997, 76 (01) : 817 - 817
  • [6] Development of resistance of human immunodeficiency virus type 1 to dextran sulfate associated with the emergence of specific mutations in the envelope gp120 glycoprotein
    Este, JA
    Schols, D
    DeVreese, K
    VanLaethem, K
    Vandamme, AM
    Desmyter, J
    DeClercq, E
    MOLECULAR PHARMACOLOGY, 1997, 52 (01) : 98 - 104
  • [7] Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization
    Hung, CS
    Vander Heyden, N
    Ratner, L
    JOURNAL OF VIROLOGY, 1999, 73 (10) : 8216 - 8226
  • [8] Structure-Function Analysis of Human Immunodeficiency Virus Type 1 gp120 Amino Acid Mutations Associated with Resistance to the CCR5 Coreceptor Antagonist Vicriviroc
    Ogert, Robert A.
    Ba, Lei
    Hou, Yan
    Buontempo, Catherine
    Qiu, Ping
    Duca, Jose
    Murgolo, Nicholas
    Buontempo, Peter
    Ralston, Robert
    Howe, John A.
    JOURNAL OF VIROLOGY, 2009, 83 (23) : 12151 - 12163
  • [9] CCR5 use by human immunodeficiency virus type 1 is associated closely with the gp120 V3 loop N-linked glycosylation site
    Clevestig, P
    Pramanik, L
    Leitner, T
    Ehrnst, A
    JOURNAL OF GENERAL VIROLOGY, 2006, 87 : 607 - 612
  • [10] Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5
    Olson, WC
    Rabut, GEE
    Nagashima, KA
    Tran, DNH
    Anselma, DJ
    Monard, SP
    Segal, JP
    Thompson, DAD
    Kajumo, F
    Guo, Y
    Moore, JP
    Maddon, PJ
    Dragic, T
    JOURNAL OF VIROLOGY, 1999, 73 (05) : 4145 - 4155